Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel in Metastatic Colorectal Cancer
NCT01639131Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in colorectal adenocarcinoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2012; status: terminated.
02
Drugs
gemcitabinedocetaxel
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01639131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639131.